ArticleAnnals of medicine and surgery (2012)2022
Third wave in India and an update on vaccination: A short communication.
Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- SARS-CoV-2 positivity rates in tear secretions of inpatient COVID-positive individuals in an Indian tertiary care setting.Indian journal of ophthalmology · 2025Article
- Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India.Viruses · 2023Article
- Quality of COVID-19 information, education and communication materials in India: A content analysis.Health education journal · 2023Article
- Semen proteomics reveals alterations in fertility-related proteins post-recovery from COVID-19.Frontiers in physiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The first case of COVID-19 was identified in December 2019. In just two years, the pandemic has wreaked a lot of havoc across the globe. Various determining factors will decide the fate of a looming third wave in India. Although there is no direct evidence of a third wave, many metro cities in India have reported a surge of new cases despite mass vaccination. The rapid development of vaccines and mass vaccination programmes has helped contain the crisis in the past. An updated and robust vaccination campaign along with public measures like the avoidance of large gatherings will help counter the third wave. Over 50% of the eligible population in India has been fully vaccinated to date. The emergence of new strains like the Alpha, Beta, Kappa, and Delta variants of concern, which may exhibit vaccine resistance, may complicate matters. Significant challenges include inadequate data collection, public unawareness, fake news, irregular vaccine supply, and the presence of mutant variants. Comorbidities like dengue complicate disease course. Travel restrictions, personal protective equipment shortages, and barriers to healthcare access are important obstacles to overcome. An increased focus on pandemic preparedness is needed. Targeted vaccination campaigns can help build a favorable public perspective. Data gathering and research need to be promoted. The nation's healthcare policy can benefit from relevant updates based on science and socio-cultural awareness. The fight against the pandemic needs to be cooperative at an international level, with adequate support meted out to resource-poor countries. Long-term structural changes to the healthcare system coupled with strategies for immediate relief will pave the way forward to a stronger system with better contingency planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.